Reported Standalone quarterly numbers for Nath Bio-Genes are:Net Sales at Rs 49.37 crore in March 2025 up 14.71% from Rs. 43.04 crore in March 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 4.71 crore in March 2025 up 46.79% from Rs. 3.21 crore in March 2024.
EBITDA stands at Rs. 7.21 crore in March 2025 up 46.54% from Rs. 4.92 crore in March 2024.
Nath Bio-Genes EPS has decreased to Rs. 2.12 in March 2025 from Rs. 2.18 in March 2024.
Nath Bio-Genes shares closed at 157.31 on April 29, 2025 (NSE) and has given -16.30% returns over the last 6 months and -23.75% over the last 12 months.
| Nath Bio-Genes | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 49.37 | 36.87 | 43.04 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 49.37 | 36.87 | 43.04 | | EXPENDITURE | | Consumption of Raw Materials | 100.62 | 84.78 | 59.02 | | Purchase of Traded Goods | 0.86 | 5.21 | 2.56 | | Increase/Decrease in Stocks | -85.95 | -77.50 | -50.14 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.51 | 10.26 | 7.08 | | Depreciation | 1.32 | 0.83 | 0.98 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | 8.85 | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 16.31 | 6.62 | 20.04 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 1.85 | 6.68 | 3.50 | | Other Income | 4.04 | 0.48 | 0.44 | | P/L Before Int., Excpt. Items & Tax | 5.89 | 7.16 | 3.94 | | Interest | 1.10 | 3.37 | 1.06 | | P/L Before Exceptional Items & Tax | 4.80 | 3.79 | 2.87 | | Exceptional Items | -- | -- | 0.95 | | P/L Before Tax | 4.80 | 3.79 | 3.82 | | Tax | 0.63 | 1.14 | 0.62 | | P/L After Tax from Ordinary Activities | 4.17 | 2.66 | 3.21 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | 0.54 | -- | -- | | Net Profit/(Loss) For the Period | 4.71 | 2.66 | 3.21 | | Equity Share Capital | 19.00 | 19.00 | 19.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.12 | 1.34 | 2.18 | | Diluted EPS | 2.12 | 1.34 | 2.18 | | EPS After Extra Ordinary | | Basic EPS | 2.12 | 1.34 | 2.18 | | Diluted EPS | 2.12 | 1.34 | 2.18 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
